Active	Status	Sponsor type	Region	Phase	Filter
28 Active 32 Inactive 60 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

28 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Maor, Yasmin
REITAB-2, NCT05204563: Imipenem/Cilastatin-XNW4107 Versus Imipenem/Cilastatin/Relebactam for Treatment of Participants With Bacterial Pneumonia (XNW4107-302, )	Recruiting	3	450	Europe, US, RoW	Combination of Imipenem/Cilastatin and XNW4107, Imipenem/Cilastatin/Relebactam, Recarbrio	Evopoint Biosciences Inc.	Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia	04/25	12/25
Goldin, Eran Mr
ASPIRE, NCT04118088 / 2017-002491-10: A Study of Darvadstrocel in Adults With Crohn's Disease and Complex Perianal Fistula	Active, not recruiting	4	50	Europe, RoW	Darvadstrocel, Alofisel, Cx601	Takeda, Takeda Development Center Americas, Inc.	Crohn's Disease, Complex Perianal Fistula	03/26	03/26
ABX464-106, NCT05507216: ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2	Recruiting	3	612	Europe, Canada, Japan, US, RoW	ABX464, Obefazimod, Placebo	Abivax S.A.	Ulcerative Colitis	03/25	04/25
VIVID-2, NCT04232553 / 2019-002687-27: A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease	Recruiting	3	778	Europe, Canada, Japan, US, RoW	Mirikizumab, LY3074828	Eli Lilly and Company	Crohn's Disease	11/24	12/26
ABTECT, NCT05535946: - Maintenance	Recruiting	3	1050	Europe, Canada, Japan, US, RoW	ABX464, Obefazimod, Placebo	Abivax S.A.	Ulcerative Colitis	01/26	01/30
LUCENT-3, NCT03519945 / 2017-004092-31: A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3) Jan 2022 - Mar 2022 : Data from LUCENT 3 trial for moderate-to-severe ulcerative colitis	Recruiting	3	1063	Europe, Canada, Japan, US, RoW	Mirikizumab, LY3074828	Eli Lilly and Company	Ulcerative Colitis	07/26	12/27
NCT03390322: Safety and Initial Performance of the DiaGone Device on Type 2 Diabetes Patients	Recruiting	N/A	16	Europe, RoW	DiaGone™	Digma Medical Ltd.	Diabetes Mellitus, Type 2	08/25	08/26
Wainstein, Julio
SURMOUNT-MMO, NCT05556512: A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity	Active, not recruiting	3	15374	Europe, Canada, Japan, US, RoW	Tirzepatide, LY3298176, Placebo	Eli Lilly and Company	Obesity, Overweight	10/27	10/27
NCT05514548: Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease	Completed	2	265	Europe, Canada, US, RoW	INV-202, None applicable, Placebo	Inversago Pharma Inc., Worldwide Clinical Trials	Diabetic Kidney Disease	08/24	09/24
Israeli, Eran
ABX464-106, NCT05507216: ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2	Recruiting	3	612	Europe, Canada, Japan, US, RoW	ABX464, Obefazimod, Placebo	Abivax S.A.	Ulcerative Colitis	03/25	04/25
ABTECT, NCT05535946: - Maintenance	Recruiting	3	1050	Europe, Canada, Japan, US, RoW	ABX464, Obefazimod, Placebo	Abivax S.A.	Ulcerative Colitis	01/26	01/30
AZITRATIM, NCT05599347: Pre-treatment With Azithromycin to Reduce Immunogenicity to to Anti-TNF Agents in Patients With Crohn's Disease	Recruiting	2	180	RoW	Azithromycin Pill, Placebo	Rambam Health Care Campus	Crohn's Disease Relapse, Biological Substance; Adverse Effect	12/25	12/26
ReDUCE, NCT05791487: Combination of Diet and Oral Budesonide for Ulcerative Colitis	Recruiting	N/A	90	Europe, RoW	Ulcerative colitis Exclusion Diet, UCED, Partial enteral nutrition (PEN), UC nutritional formula, Nestle, free diet, Oral Budesonide	Wolfson Medical Center	Ulcerative Colitis, Ulcerative Colitis Chronic Mild, Ulcerative Colitis Chronic Moderate	03/26	09/26
NCT04940611: A Study of Surgical Interventions in Fistulizing Conditions	Active, not recruiting	N/A	750	Europe, Canada, US, RoW		Takeda	Crohns Disease, Fistula, Rectovaginal Fistula, Complex Perianal Fistula, Complex Cryptoglandular Fistula	05/26	05/26
Gluck, Ohad
NCT05921071: Do Patients Who Received Tranexamic Acid in Vaginal Hysterectomy Loose Les Blood, Comparing to Patients Who Did Not?	Recruiting	N/A	80	RoW	Tranexamic acid, Hexakapron, Placebo, Normal Selaine 0.9%	Wolfson Medical Center	Vaginal Hysterectomy	06/24	01/25
Avni-Biron, Irit
ABX464-106, NCT05507216: ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2	Recruiting	3	612	Europe, Canada, Japan, US, RoW	ABX464, Obefazimod, Placebo	Abivax S.A.	Ulcerative Colitis	03/25	04/25
ABTECT, NCT05535946: - Maintenance	Recruiting	3	1050	Europe, Canada, Japan, US, RoW	ABX464, Obefazimod, Placebo	Abivax S.A.	Ulcerative Colitis	01/26	01/30
Rubinshtein, Ronen
Arineta, NCT02616939: Clinical In-hospital Evaluation of the Usefulness of a New Multi-detector Computed Tomography Scanner From Ltd	Recruiting	N/A	400	RoW	Cardiac CT scanning (with the SpotLight CT)	Carmel Medical Center, Arineta Ltd.	Coronary Artery Disease	11/20	11/22
TRIBUTE, NCT05767645: Mistral Percutaneous Tricuspid Valve Durable Repair Pivotal Study	Recruiting	N/A	75	RoW	Mistral Procedure	Mitralix	Tricuspid Valve Regurgitation	03/24	09/25
Israelson, Mary
TRIBUTE, NCT05767645: Mistral Percutaneous Tricuspid Valve Durable Repair Pivotal Study	Recruiting	N/A	75	RoW	Mistral Procedure	Mitralix	Tricuspid Valve Regurgitation	03/24	09/25
Steiner, Hillel
BIO|STREAM HF, NCT03366545: Observation of Clinical Routine Care for Heart Failure Patients Implanted With BIOTRONIK CRT Devices	Recruiting	N/A	3000	Europe, Japan, RoW	Cardiac Resynchronization Therapy (CRT)	Biotronik SE & Co. KG	Heart Failure	12/24	06/25
Kleiner, Ilia
NCT05187247: VR Glasses During Induction of Labour for Pain and Anxiety Relieve	Recruiting	N/A	145	RoW	Virtual Reality glasses	Wolfson Medical Center	Virtual Reality, Induction of Labor Affected Fetus / Newborn, Extra Amniotic Balloon	11/22	05/23
Silbershatz, Itay
MANIFEST-2, NCT04603495 / 2020-001989-10: Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) Jan 2024 - Dec 2024: Approval for myelofibrosis Jan 2024 - Mar 2024: From MANIFEST-2 trial in combination with ruxolitinib as a first-line treatment for patients with myelofibrosis Feb 2024 - Feb 2024: Completion of P2b trial for JIA Feb 2024 - Feb 2024: Exclusivity expiry in US	Active, not recruiting	3	430	Europe, Canada, US, RoW	Pelabresib, Ruxolitinib, Placebo	Constellation Pharmaceuticals	Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis	08/23	12/27
Tamayev, Lilia
NCT05648721: The Effects of a Digital Application for GDM Management in Improving Patients' Compliance	Recruiting	N/A	110	RoW	Datos mobile health application, Regular follow-up	The Baruch Padeh Medical Center, Poriya, Bar-Ilan University, Israel	Gestational Diabetes, Pregnancy in Diabetic	12/25	04/26
Abarbanel, Almog
REITAB-2, NCT05204563: Imipenem/Cilastatin-XNW4107 Versus Imipenem/Cilastatin/Relebactam for Treatment of Participants With Bacterial Pneumonia (XNW4107-302, )	Recruiting	3	450	Europe, US, RoW	Combination of Imipenem/Cilastatin and XNW4107, Imipenem/Cilastatin/Relebactam, Recarbrio	Evopoint Biosciences Inc.	Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia	04/25	12/25
Okropiridze, Nana
NCT05514548: Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease	Completed	2	265	Europe, Canada, US, RoW	INV-202, None applicable, Placebo	Inversago Pharma Inc., Worldwide Clinical Trials	Diabetic Kidney Disease	08/24	09/24
Griner, Tomer
NCT05657743: A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer	Recruiting	N/A	15	RoW	Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)	Alpha Tau Medical LTD.	Pancreatic Cancer, Unresectable Pancreatic Cancer, Metastatic Pancreatic Cancer, Pancreatic Adenocarcinoma	11/25	11/25
Friedman, Matan
NCT06375746: The Impact of a Customized Informative Video Prior to Induction of Labor on Anxiety Relieve.	Recruiting	N/A	180	RoW	Personalized video, Video group	Wolfson Medical Center	Induction of Labor Affected Fetus / Newborn	08/24	08/24